Pharmacokinetic‐tailored approach to hemophilia prophylaxis: Medical decision making and outcomes

摘要

Clinical application of population pharmacokinetics (popPK) is of increasing interest to patients with hemophilia, providers, and payers. Routine use of popPK profiles in factor replacement prophylaxis decision making has the potential to maintain or improve efficacy and reduce product consumption.